Lundi 28 septembre 2020 - 08:08 | A ne pas manquer : Le 10 Septembre 2020 - Réunion de la Banque centrale européenne



Présentation de la société
LeGuideBoursier.com

Description de la société pas encore définie

Nitinol compression anastomosis at major french surgical meetings

  • Publié le Lundi 29 avril 2013 à 19:25
  • Catégorie : ,
  • Source : Actusnews

Enthusiastic Response to Clinical Sessions and Broadcast of Live Surgery
ATLANTA, April 29, 2013 (GLOBE NEWSWIRE) -- novoGI Inc. today announced that its nitinol compression anastomosis technology and novoGI™ ColonRing device were the focus of several scientific sessions at recent gastrointestinal (GI) surgery meetings in France, the 16th Journées de Chirurgie Digestive held in Bordeaux and the Journées de Chirurgie Digestive de Beaujon in Paris.

Sessions by leading colorectal surgeons focused on recently published data for successful outcomes for novoGI™ ColonRing in terms of low leak rates of 1.9% - 4% and healing processes for low anterior resection (LAR) procedures, training methods, and ease of use for the surgical technique.

Prof Eric Rullier, MD (University Hospital, Bordeaux, France) led the session novoGI Symposium Anastome colorectale par compression. During the same podium session, Prof Paul-Antoine Lehur, MD (CHU de Nantes, Nantes, France) presented the World Congress of Compression Anastomosis (WCCA), its organization and goals, focusing on training methods. At the Paris meeting, Prof Yves Panis, MD, PhD (Beaujon Hospital, Clichy, France) demonstrated the surgical technique using the novoGI™ ColonRing compression anastomosis device in an LAR procedure which was broadcast live to participants.

"We are very excited about the enthusiastic response to novoGI's compression anastomosis technology – the clinical results and the actual surgical technique – presented at these scientific meetings as well as last month's annual French congress of 4,000 gastroenterologists, Journées Francophones d'Hepato-gastroeneterologie et d'Oncologies Digestive (JFHOD), which included 4,000 medical professionals," commented Jean-Paul Durand, novoGI Corporate Vice President and General Manager for Europe.

"The success of recent events in France demonstrates novoGI's growing global presence," novoGI President and Chief Executive Officer, Gavriel D. Meron noted. "As we progress through this week's sessions of the American Society of Colon & Rectal Surgeons (ASCRS) 2013 Annual Meeting in Phoenix, Arizona, we look forward to next week's scientific symposium on novoGI's nitinol compression anastomosis in Munich at the regional German conference of 8,000 surgeons."

About novoGI
novoGI
is focused on providing an expanding range of solutions for GI disease management through a globally branded, high quality, market driven company. The US headquarters are in Atlanta, Georgia; research, development and manufacturing facilities in Netanya, Israel; and its European headquarters are near Paris, France. The company's website is www.novoGI.com.

NOVOGI, the NOVOGI logo, the GI logo, and DEFINING THE FUTURE are trademarks and/or registered trademarks of novoGI Inc.
CONTACT: For further information contact:
[email protected]
www.novoGI.com



Information non réglementée

Communiqué intégral et original au format PDF :
http://www.actusnews.com/documents_communiques/ACTUS-0-31806-novoGI-ENGLISH.pdf
© Copyright Actusnews Wire
Recevez gratuitement par email les prochains communiqués de la société en vous inscrivant sur www.actusnews.com
Receive by email the next press releases of the company by registering on www.actusnews.com, it's free

Article précédent

Phoenix Software International fournit un kit de développement logiciel optionnel pour sa suite logicielle de saisie de données

Ce contenu est diffusé par Hugin, il n`a qu`une portée informative et pédagogique.Les informations et données financières ainsi que les analyses diffusées par Hugin n`ont aucune valeur contractuelle et ne constituent en aucun cas une aide à la décision, une offre de vente ou une sollicitation d`achat de valeurs mobilières ou d`instruments financiers.

La responsabilité de LeGuideBoursier.com et/ou de ses dirigeants et salariés ne peut être retenue directement ou indirectement suite à l`utilisation des informations et analyses par les lecteurs et sur la pertinence des informations diffusées.

Il est recommandé à toute personne non avertie de consulter un conseiller professionnel avant tout investissement, car le trading peut vous exposer à des pertes supérieures aux dépôts chez votre broker.

Tout investisseur doit se faire son propre jugement avant d`investir dans un produit financier afin qu`il soit adapté à sa situation financière, fiscale et légale

Vous aimerez aussi